NYSEAMERICAN:ASXC Asensus Surgical (ASXC) Stock Price, News & Analysis $0.34 0.00 (0.00%) (As of 07/5/2024 ET) Add Compare Share Share Today's Range$0.33▼$0.3450-Day Range N/A52-Week Range$0.20▼$0.65Volume1.73 million shsAverage Volume4.59 million shsMarket Capitalization$91.83 millionP/E RatioN/ADividend YieldN/APrice Target$0.68 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Asensus Surgical alerts: Email Address Asensus Surgical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside100.2% Upside$0.68 Price TargetShort InterestHealthy4.30% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.24) to ($0.13) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.83 out of 5 stars 3.0 Analyst's Opinion Consensus RatingAsensus Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAsensus Surgical has only been the subject of 1 research reports in the past 90 days.Read more about Asensus Surgical's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.30% of the float of Asensus Surgical has been sold short.Short Interest Ratio / Days to CoverAsensus Surgical has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in Asensus Surgical has recently decreased by 11.15%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAsensus Surgical does not currently pay a dividend.Dividend GrowthAsensus Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASXC. Previous Next 3.3 News and Social Media Coverage News SentimentAsensus Surgical has a news sentiment score of 1.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Asensus Surgical this week, compared to 1 article on an average week.Search Interest5 people have searched for ASXC on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Asensus Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Asensus Surgical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.87% of the stock of Asensus Surgical is held by insiders.Percentage Held by InstitutionsOnly 9.35% of the stock of Asensus Surgical is held by institutions.Read more about Asensus Surgical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Asensus Surgical are expected to grow in the coming year, from ($0.24) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Asensus Surgical is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Asensus Surgical is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAsensus Surgical has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. About Asensus Surgical Stock (NYSEAMERICAN:ASXC)Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.Read More ASXC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASXC Stock News HeadlinesJuly 3, 2024 | americanbankingnews.comAsensus Surgical, Inc. (NYSEAMERICAN:ASXC) Short Interest Down 11.2% in JuneJune 24, 2024 | globenewswire.comAsensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery ProgramJuly 7, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.June 13, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, ASXC on Behalf of ShareholdersJune 13, 2024 | businesswire.comASENSUS SURGICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Asensus Surgical, Inc. - ASXCJune 7, 2024 | prnewswire.comSHAREHOLDER ALERT: The M&A Class Action Investigates the Merger of Asensus Surgical, Inc. - ASXCJune 7, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Asensus Surgical, Inc. has obtained a Fair Price for its Public ShareholdersJune 7, 2024 | businesswire.comASXC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Asensus Surgical, Inc. Is Fair to ShareholdersJuly 7, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.June 7, 2024 | globenewswire.comAsensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZMay 16, 2024 | markets.businessinsider.comAsensus Surgical Hold Rating: Balancing Modest Growth and Acquisition ProspectsMay 15, 2024 | msn.comAsensus Surgical, Inc. (AMEX:ASXC) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comAsensus Surgical Inc (ASXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...May 14, 2024 | markets.businessinsider.comAsensus Surgical earnings: here's what Wall Street expectsMay 14, 2024 | finance.yahoo.comAsensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024May 14, 2024 | globenewswire.comAsensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024May 7, 2024 | globenewswire.comAsensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024April 29, 2024 | globenewswire.comAsensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery ProgramSee More Headlines Receive ASXC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSEAMERICAN:ASXC CUSIPN/A CIKN/A Webwww.asensus.com Phone(919) 765-8400Fax919-765-8459Employees207Year FoundedN/APrice Target and Rating Average Stock Price Target$0.68 High Stock Price Target$1.00 Low Stock Price Target$0.35 Potential Upside/Downside+100.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,430,000.00 Net Margins-902.25% Pretax Margin-899.16% Return on Equity-184.10% Return on Assets-114.75% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.69 Sales & Book Value Annual Sales$8.58 million Price / Sales10.70 Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / Book2.59Miscellaneous Outstanding Shares272,330,000Free Float264,516,000Market Cap$91.83 million OptionableNot Optionable Beta1.37 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Anthony Fernando (Age 52)President, CEO & Director Comp: $901.03kMr. Shameze Rampertab B.Sc. MBA (Age 57)CA, CPA, Executive VP & CFO Comp: $511.25kMr. Joshua B. Weingard (Age 51)Chief Legal Officer & Secretary Mr. Paul Ziegler Jr. (Age 50)J.D., Vice President of Sales Mr. Ethan LoiselleVice President of Global MarketingMs. Amanda OwensVice President of PeopleMr. Ravi KommineniHead of Global Quality & RegulatoryMr. Motti FrimerVice President of R&D, Digital Solutions and MD of Asensus SurgicalMore ExecutivesKey CompetitorsCerusNASDAQ:CERSSight SciencesNASDAQ:SGHTNevroNYSE:NVROOraSure TechnologiesNASDAQ:OSURTactile Systems TechnologyNASDAQ:TCMDView All CompetitorsInsiders & InstitutionsVirtu Financial LLCBought 222,368 shares on 5/20/2024Ownership: 0.091%William N Starling JrBought 18,134 shares on 12/14/2023Total: $5,077.52 ($0.28/share)View All Insider TransactionsView All Institutional Transactions ASXC Stock Analysis - Frequently Asked Questions How have ASXC shares performed this year? Asensus Surgical's stock was trading at $0.2466 at the beginning of the year. Since then, ASXC shares have increased by 36.7% and is now trading at $0.3372. View the best growth stocks for 2024 here. How were Asensus Surgical's earnings last quarter? Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) posted its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.02. The firm had revenue of $1.12 million for the quarter, compared to analyst estimates of $1.10 million. Asensus Surgical had a negative net margin of 902.25% and a negative trailing twelve-month return on equity of 184.10%. How do I buy shares of Asensus Surgical? Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:ASXC) was last updated on 7/7/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asensus Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Asensus Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
